Pharmacoeconomics of Immunisation
- 1 April 1993
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 3 (4), 286-308
- https://doi.org/10.2165/00019053-199303040-00005
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Cost-effectiveness analysis of prenatal screening and vaccination against hepatitis B virus—The case of BelgiumSocial Science & Medicine, 1993
- The Economics of Screening for MeaslesPharmacoEconomics, 1992
- Review of Cost-Benefit Analyses of Influenza VaccinePharmacoEconomics, 1992
- Principles of Pharmacoeconomic Analysis of Drug TherapyPharmacoEconomics, 1992
- Hepatitis B: the diseaseVaccine, 1990
- Hepatitis B: transmission by sexual contact and needle sharingVaccine, 1990
- Risk factors of invasive Haemophilus influenzae type b disease among children in FinlandThe Journal of Pediatrics, 1989
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987
- Syphilis, hepatitis A, hepatitis B, and cytomegalovirus infection in homosexual men in Antwerp.Sexually Transmitted Infections, 1984
- Indications for Use of Hepatitis B Vaccine, Based on Cost-Effectiveness AnalysisNew England Journal of Medicine, 1982